


下載本文檔
版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡介
1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEMT-DADMe-ImmACat. No.: HY-101496CAS No.: 653592-04-2Synonyms: Methylthio-DADMe-Immucillin A; MTDIA分式: CHNOS分量: 293.39作靶點(diǎn): Others作通路: Others儲存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性數(shù)據(jù)體外實(shí)驗(yàn) DMSO : 33
2、.33 mg/mL (113.60 mM)* means soluble, but saturation unknown.Mass Solvent1 mg 5 mg 10 mg Concentration制備儲備液1 mM 3.4084 mL 17.0422 mL 34.0843 mL5 mM 0.6817 mL 3.4084 mL 6.8169 mL10 mM 0.3408 mL 1.7042 mL 3.4084 mL請根據(jù)產(chǎn)品在不同溶劑中的溶解度,選擇合適的溶劑配制儲備液,并請注意儲備液的保存式和期限。BIOLOGICAL ACTIVITY物活性 MT-DADMe-ImmA5-甲硫基腺苷磷
3、酸化酶的抑制劑 (MTAP),Ki值為90 pM。IC50 & Target Ki: 90 pM (MTAP) 1體外研究Treatment of cultured cells with MT-DADMe-ImmA and MTA inhibit MTAP, increase cellular MTA1/2 Master of Small Molecules 您邊的抑制劑師www.MedChemEconcentrations, decrease polyamines, and induce apoptosis in FaDu and Cal27, two head and necksquamo
4、us cell carcinoma cell lines. The same treatment does not induce apoptosis in normal humanfibroblast cell lines (CRL2522 and GM02037) or in MCF7, a breast cancer cell line with an MTAP genedeletion. MT-DADMe-ImmA alone does not induce apoptosis in any cell line, implicating MTA as the activeagent 2.
5、體內(nèi)研究 The t1/2 for onset of inhibition is 50 min with complete inhibition by 250 min. MTAP activity slowly returns,giving a biological half-life for the action of oral MT-DADMe-ImmA of 6.3 days. The time-dependent growth ofFaDu tumors in immunodeficient mice is suppressed by oral or intraperitoneal t
6、reatment with MT-DADMe-ImmA 2.PROTOCOLCell Assay 2 Cell viability is evaluated using the Alamar Blue assay. Cells are seeded onto 96-well plates at a density of104 cells/well and incubated with increasing concentrations of MT-DADMe-ImmA (100 pM to 100 M) for 4days at fixed MTA concentrations (0, 5,
7、10, and 20 M). IC50 is determined with the assay data 2.MCE has not independently confirmed the accuracy of these methods. They are for reference only.Animal Mice: Tumors were established in mice for 5 days prior to oral or intraperitoneal treatments with MT-DADMe-Administration 1 ImmA. Mice are tre
8、ated with oral dose of 21 mg/kg or an intraperitoneal dose of 5 mg/kg/day MT-DADMe-ImmA 2.MCE has not independently confirmed the accuracy of these methods. They are for reference only.REFERENCES1. Evans GB, et al. Second generation transition state analogue inhibitors of human 5-methylthioadenosine phosphorylase. J Med Chem.2005 Jul 14;48(14):4679-89.2. Basu I, et al. A transition state analogue of 5-methylthioadenosine phosphorylase induces apoptosis in head and neck cancers. J BiolChem. 2007 Jul 20;282(29):21477-86.McePdfHeightCaution: Product has not been fully validated for medical a
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 精釀原料知識培訓(xùn)課件
- 學(xué)前班個(gè)人工作總結(jié)范文(32篇)
- 2025年灌封膠合作協(xié)議書
- 2025年小學(xué)教育改革:教案創(chuàng)新與發(fā)展
- 船標(biāo)員專業(yè)知識培訓(xùn)課件
- 利尿脫水及降顱壓藥物課件
- 如何提高工作質(zhì)量
- 泵站運(yùn)行安全協(xié)議書
- 電子信息行業(yè)智能化電子產(chǎn)品生產(chǎn)與測試方案
- 生產(chǎn)流程管理操作手冊
- 《同濟(jì)大學(xué)簡介》課件
- 《建筑攝影5構(gòu)》課件
- 機(jī)電安裝工程質(zhì)量控制
- 愛自己是終身浪漫的開始 心理課件
- 新房房屋買賣合同
- 地鐵出入口雨棚施工工藝
- 人工智能引論智慧樹知到課后章節(jié)答案2023年下浙江大學(xué)
- 文獻(xiàn)的載體課件
- 大學(xué)專科《機(jī)電傳動(dòng)控制》課件
- 品管圈QCC質(zhì)量持續(xù)改進(jìn)案例手術(shù)室-優(yōu)化手術(shù)病理標(biāo)本處置流程PDCA
- 基于核心素養(yǎng)的學(xué)習(xí)觀和教學(xué)觀
評論
0/150
提交評論